Tempest Therapeutics, Inc.
TPSTDrugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Oct 1, 2026
13dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
Trial Start — In Vivo CAR-T
Tempest Therapeutics unveiled its next-generation in vivo CAR-T pipeline with plans to initiate the first clinical study in Q4 2026.
SourceHow TPST's past catalysts played out
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is Tempest Therapeutics, Inc.'s next FDA catalyst?→
Tempest Therapeutics, Inc.'s (TPST) next tracked catalyst is a Trial Start expected October 1, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track TPST biotech catalysts?→
Add TPST to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Tempest Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.